AzTrials
AzTrials

Lower Cross SyndromeNCT06613620

Additional Effects of Surface Electromyographic Biofeedback on Post Facilitation Stretching and Strengthening in Lower Crossed Syndrome;A Randomized Control Trial

A study testing Standard Treatment, Visual and auditory feedback on SEMG biofeedback unit and Electrical muscle stimulation in people with Lower Cross Syndrome, run by Foundation University Islamabad at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a randomised control trial and the purpose of this study is to determine the additional effects of surface electromyographic biofeedback on post facilitation stretching and strengthening in lower crossed syndrome. . Read more about this study

Who is it for?
Ages 19 to 35 years
Conditions the study is for
Lower Cross Syndrome
What is being tested?
Standard Treatment, Visual and auditory feedback on SEMG biofeedback unit and Electrical muscle stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 sitePakistan
Study dates
18 Jul 2024to 20 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 19-35 years
  • Both genders
  • Positive modified Thomas test
  • Positive prone hip extension strength test
  • Positive trunk flexion strength test
  • Tight erector spinae
Show all 11Show fewer
  • BMI normal (18.5-24.9 Kg/m2)
  • Local intermittent lumbar pain
  • moderate pain (NPRS 3-7)
  • Painless movement and activity
  • Pain only produced by sustained loading in relevant position, which is then relieved on moving from that pos

Who cannot join

  • Acute flare of LBP
  • Centralization and peripheralization of pain
  • Signs of stenosis(leg symptoms when walking that are eased upon flexion)
  • Pain due to repetitive movements
  • Paresthesia/Numbness
  • Structual deformity(Kyphosis, spondylosis, spondylolisthesis,scoliosis and joint contractures)
Show all 10Show fewer
  • Curve reversal
  • Pregnancy
  • Post surgery
  • Degenerative and inflammatory spine diseases

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Foundation University College of Physical Therapy

    Punjāb Chak, Punjab Province, 46000

Other trials in Pakistan

About this study

This study is a randomised control trial and the purpose of this study is to determine the additional effects of surface electromyographic biofeedback on post facilitation stretching and strengthening in lower crossed syndrome.

.

Read the detailed description

Participants will be recruited into their respective groups using a sealed envelope method. Lower crossed syndrome will be assessed using the following tests:

Prone hip extension test Trunk flexion strength test Tightness in erector spinae Modified Thomas test

Being tested
Standard Treatment, Visual and auditory feedback on SEMG biofeedback unit, Electrical muscle stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard TreatmentOther

    All participants will receive 4 weeks of intervention with a frequency of 3 times/week i.e. 10minutes of hot pack followed by post facilitation stretching and strengthening protocol.

    The exercise protocol will be taught to the patient by an experienced physiotherapist and supervised on the subsequent sessions. The protocol will be gradually progressed as per the patient's tolerance.

  • Visual and auditory feedback on SEMG biofeedback unitOther

    Patients will receive SEMG biofeedback assisted post facilitation stretching and strengthening. Patients will receive 50-80%of their maximum voluntary contraction as per the biofeedback and gradually the contraction time will be increased.

  • Electrical muscle stimulationOther

    Electrical muscle stimulation will be provided in addition to visual and auditory feedback by the SEMG biofeedback unit to the weak muscles until the patients achieve the desired level of contractions.

Study groups in NCT06613620
Study groupRoleWhat they receive
Post Facilitation Stretching and StrengtheningExperimentalGroup A will recieve standard treatment of post facilitation stretching and strengthening. Strengthening will be divided into following phases 1. Warm up phase: 2. Strengthening phase: 3. Cool down phase:
Receives: Other: Standard Treatment
Visual and auditory biofeebackExperimentalGroup B will receive surface EMG biofeedback(visual and auditary) in addition to standard treatment.
Receives: Other: Standard Treatment; Other: Visual and auditory feedback on SEMG biofeedback unit
Electrical stimulation along with visual and auditory feedbackExperimentalGroup C will receive 3 types of feedbacks (electrical, visual and auditory) in addition to standard treatment
Receives: Other: Standard Treatment; Other: Visual and auditory feedback on SEMG biofeedback unit; Other: Electrical muscle stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lumber lordotic angle

    It will be measured using a mobile application. One sensor will be placed at the T12-L1 and other at L5-S1 spinous processes. The two angles will be recorded and their sum will be considered as the lumber lordotic angle.

    Measured: 4 weeks

  2. Joint position sense

    One sensor will be placed at T12-L1 and the other placed at L5-S1 simultaneously. Patient will be asked to flex and then extend maximally; his end ranges will be recorded. Within the middle range, therapist will decide the targeted angle for individualized patient. Patient will be asked to memorize the target position for 5seconds. The absolute error will measure by subtracting the actual angle and the target angle.

    Measured: 4 weeks

  3. pain intensity

    It will be measured on a numeric pain rating scale in which the subjects select a number ranging from 0-10 according to their intensity of pain. '0' score indicates no pain while '10' indicates worst pain experienced.

    Measured: 4 weeks

  4. Functional disability

    It will be measured using a Modified Oswestry lower back Disability Index. It is a 10item based questionnaire and each item is further divided into 6statements. The score of '0-4' indicated no disability while 35-50 indicate complete disability.

    Measured: 4 Weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2024
  2. Study start18 Jul 2024
  3. Primary completion2 Jun 2025
  4. Study completion20 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Control Trial
Masking
None (open label)
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06613620
Sponsor's protocol ID
FUI/CTR/2024/33
Status last verified
Dec 2025
First submitted
23 Sep 2024
Last updated
22 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Standard Treatment, Visual and auditory feedback on SEMG biofeedback unit and Electrical muscle stimulation in people with Lower Cross Syndrome, run by Foundation University Islamabad at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lumber lordotic angle (time frame: 4 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in